India Drug Device Combination Products Market (2025-2030)
The India Drug Device Combination Products Market was valued at $4389 Million in 2025 and projected to reach to $8082.8 Million by 2030, representing a compound annual growth rate of 13.0%. India's drug device combination products market is poised for exceptional growth, expanding from USD 4,389 million in 2025 to USD 8,082.8 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Drug Device Combination Products Market Trends and Insights
- This accelerated expansion in India reflects increasing healthcare investments, rising chronic disease prevalence, and growing adoption of advanced therapeutic solutions across the country.
- India's market growth significantly outpaces the global average of 9.3% CAGR, positioning the nation as a high-growth hub within the Asia Pacific region. The drug device combination products sector in India is driven by expanding pharmaceutical manufacturing capabilities, regulatory modernization, and heightened demand for integrated treatment solutions in diabetes, cardiovascular disease, and respiratory conditions.
- India's cost-effective manufacturing ecosystem and large patient population create substantial opportunities for both domestic and international players.
- Between 2025 and 2030, India is expected to capture increasing market share as healthcare infrastructure improvements and government initiatives support broader access to combination therapies throughout the country..
Key Market Statistics
- CAGR (2025-2030) 13.0% CAGR
- Market Size, 2025 ~USD 4389 Million
- Forecast, 2030 ~USD 8082.8 Million
- Country India
India Drug Device Combination Products Market Overview
Rapid Market Expansion :
India's drug device combination products market is growing at 13% CAGR, significantly outpacing the global growth rate of 9.3%, driven by increased healthcare spending and government initiatives like Ayushman Bharat.
Rising Chronic Disease Burden :
Growing prevalence of diabetes, cardiovascular diseases, and respiratory conditions in India is accelerating demand for integrated therapeutic solutions that combine pharmaceutical and medical device components.
Healthcare Infrastructure Investment :
Substantial investments in India's healthcare infrastructure, coupled with expanding hospital networks and diagnostic centers, are creating favorable conditions for adoption of advanced combination products.
Regulatory Framework Evolution :
India's regulatory bodies are streamlining approval pathways for combination products, reducing time-to-market and encouraging both domestic manufacturers and international players to expand their portfolios in the country.
India Drug Device Combination Products Market Dynamics
- This trajectory reflects India's transformation into a global healthcare hub, supported by increasing healthcare accessibility, rising disposable incomes, and growing awareness of advanced treatment options among both urban and semi-urban populations. The market's expansion is underpinned by strategic government healthcare policies, pharmaceutical manufacturing capabilities, and a large patient population requiring chronic disease management.
- Domestic manufacturers are increasingly innovating in combination products, while international companies are establishing local partnerships to capture market share.
- The convergence of affordability, innovation, and regulatory support positions India as a critical growth engine for the global drug device combination products sector..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Becton, Dickinson and Company
- Novo nordisk a/s
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- India's drug device combination products market will nearly double from USD 4,389.0 million in 2025 to USD 8,082.8 million by 2030, driven by a 13.0% CAGR that exceeds global growth rates.
- India's expanding healthcare infrastructure, rising chronic disease burden, and government health initiatives are accelerating adoption of combination products across the country.
- India's cost-competitive manufacturing base and large patient population position the nation as a critical growth engine for both domestic and multinational combination product manufacturers.
- Regulatory modernization and increased healthcare spending in India are enabling faster market penetration of advanced drug-device combination therapies through 2030.
Drug Device Combination Products Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | OBESITY MANAGEMENT (Application) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 9.3% from 2025 to 2030 |
| Largest Segment | INJECTABLE DRUG DELIVERY DEVICES (Product Type) |
| Market Size Base Year (Billions) | ~USD 243.07 (2025) |
| Revenue Forecast (Billions) | ~USD 379.17 (2030) |
| Segments Covered | Product Type, Type, Application, End User |
India Drug Device Combination Products Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product Type
- Drug-Coated Balloons
- Drug-Eluting Stents
- Infusion Pumps
- Inhalers
- Injectable Drug Delivery Devices
- Other Product Types
- Transdermal Patches
By Type
- Autoinjectors
- Needle-Free Injectors
- Pen Injectors
- Prefilled Syringes
- Wearable Injectors
By Application
- Autoimmune Diseases
- Cardiovascular Diseases
- Diabetes Management
- Infectious Diseases
- Obesity Management
- Oncology
- Opthamology
- Other Applications
- Pain Management
- Respiratory Diseases
By End User
- Ambulatory Surgery Centers
- Home Care Settings
- Hospitals & Clinics
- Long-Term Care Facilities
- Other End Users
Target Audience
- Pharmaceutical Manufacturers : Need India-specific market data to evaluate combination product opportunities, assess competitive positioning, and develop localized go-to-market strategies in this rapidly expanding therapeutic segment.
- Medical Device Companies : Require detailed India market insights to identify partnership opportunities with pharma companies, understand regulatory requirements, and plan product portfolio expansion in combination products.
- Healthcare Investors & PE Firms : Seek validated market sizing and growth forecasts for India to evaluate investment opportunities, assess portfolio company potential, and benchmark performance against regional market trends.
- Healthcare Consultants & Advisors : Need India-focused market intelligence to support client strategy development, due diligence activities, and market entry planning for combination product businesses and healthcare ventures.
- Government & Regulatory Bodies : Require market data to inform healthcare policy decisions, reimbursement frameworks, and regulatory guidelines that support innovation and accessibility of combination products across India.
Reasons to Buy this Report
- Market Size & Growth Validation : Access precise market valuation for India (USD 4,389M in 2025) and verified 5-year forecast data to support investment decisions, business planning, and competitive positioning in this high-growth market.
- India-Specific Growth Drivers : Understand localized factors driving 13% CAGR—including healthcare policy changes, disease prevalence trends, and infrastructure development—that differ from global market dynamics and require tailored strategies.
- Competitive Landscape Intelligence : Identify market opportunities, regulatory pathways, and competitive gaps specific to India's drug device combination products sector to inform product development, partnerships, and market entry strategies.
- Stakeholder Alignment : Leverage India-focused market data to align internal teams, justify budget allocations, and communicate growth potential to investors, boards, and partners with credible, region-specific insights.
- Risk Mitigation & Forecasting : Reduce market entry risks by understanding India's unique regulatory environment, reimbursement landscape, and adoption patterns to develop realistic financial projections and contingency planning.
Frequently asked questions
What is the projected market size for drug device combination products in India by 2030?
India's drug device combination products market is projected to reach USD 8,082.8 million by 2030, growing from USD 4,389.0 million in 2025.
What is the CAGR for India's drug device combination products market?
India's drug device combination products market is expected to grow at a compound annual growth rate of 13.0% between 2025 and 2030.
Why is India's market growth rate higher than the global average?
India's 13.0% CAGR exceeds the global 9.3% average due to expanding healthcare infrastructure, rising chronic disease prevalence, cost-effective manufacturing, and government health initiatives driving combination product adoption.
What factors are driving growth in India's drug device combination products market?
Key drivers in India include increasing healthcare investments, rising prevalence of chronic diseases, regulatory modernization, expanding pharmaceutical manufacturing capabilities, and growing demand for integrated treatment solutions.
How does India's market position compare within Asia Pacific?
India represents a high-growth hub within Asia Pacific, with its 13.0% CAGR positioning the country as a critical market for drug device combination products expansion through 2030.
RESEARCH METHODOLOGY
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies, and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), American Journal of Drug Delivery and Therapeutics, International Diabetes Federation (IDF), American Association of Diabetes Educators (AADE), Asian Association for the Study of Diabetes (AASD) and Parenteral Drug Association (PDA) were referred to identify and collect information for the global drug device combination products market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the drug device combination products market. The primary sources from the demand side include hospitals & clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-levels include CEOs, CFOs, COOs, and VPs.
*Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global drug device combination products market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70–75% of the market share at the global level). Also, the global drug device combination products market was split into various segments and sub-segments based on:
- List of major players operating in the drug device combination products market at the regional and/or country level
- Product mapping of various drug device combination product manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from drug device combination products (or the nearest reported business unit/product category)
- Revenue mapping of major players to cover at least 70–75% of the global market share as of 2024
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global point-of-care diagnostics market
Market Size Estimation (Bottom-up approach and Top-down approach)
Data Triangulation
After arriving at the overall size of the global drug device combination products market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
A combination product is defined as any amalgamation of a drug and a device, a biological product and a device, a drug and a biological product, or a triad comprising a drug, device, and biological product. This category encompasses products that consist of two or more regulated entities—such as drug/device, biologic/device, drug/biologic, or drug/device/biologic—that are integrated or formulated as a single entity through various physical, chemical, or other methodologies. Moreover, combination products may also refer to distinct components that are packaged either as a single unit or as a collaborative assembly of biological and drug compounds, device-to-device pairings, or drug and device integrations.
Stakeholders
- Drug device combination products manufacturers and distributors
- Healthcare institutions (hospitals, medical schools, and outpatient clinics)
- Research institutes
- Contract manufacturing organizations (CMOs)
- Market research and consulting firms
- Venture capitalists and investors
- Market research and consulting firms
- Government Bodies/Municipal Corporations
- Regulatory Bodies
- Medical Research Institutes
- Business Research and Consulting Service Providers
Report Objectives
- To define, measure, and describe the global drug device combination products market by product type, application, end user, and region
- To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
- To strategically analyze the regulatory analysis, pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically analyze the market structure, profile the key players in the global drug device combination products market, and comprehensively analyze their core competencies
- To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the drug device combination products market
- To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global drug device combination products market
Get the Full Drug Device Combination Products Market Report
Full forecast, segment splits, and company analysis for all Drug Device Combination Products Market.
- US Drug Device Combination Products Market
- Canada Drug Device Combination Products Market
- UK Drug Device Combination Products Market
- Germany Drug Device Combination Products Market
- France Drug Device Combination Products Market
- Italy Drug Device Combination Products Market
- Spain Drug Device Combination Products Market
- China Drug Device Combination Products Market
- Japan Drug Device Combination Products Market
- South Korea Drug Device Combination Products Market
- Australia Drug Device Combination Products Market
- Brazil Drug Device Combination Products Market
- Mexico Drug Device Combination Products Market
- UAE Drug Device Combination Products Market
- Rest Of Europe Drug Device Combination Products Market
- Rest Of Asia Pacific Drug Device Combination Products Market
- Rest Of GCC Countries Drug Device Combination Products Market
- Rest Of Latin America Drug Device Combination Products Market
- Kingdom Of Saudi Arabia Drug Device Combination Products Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report